As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Proficiency Testing (PT) is an important tool to enhance the quality management of the laboratory and to evaluate and improve the technical capabilities of the laboratory. The result of PT can be taken as a reference for undertaking corresponding inspection and testing tasks. National Institute of Food and Drug Control (NIFDC) is responsible for drug testing, technical arbitration and quality evaluation in China. CFDA assigns NIFDC to responsible of the food and drug testing and verification in China. The new Chinese GLP, which effectives on September 1, 2017, requires that all of the drug safety evaluation research institute to participate the proficiency testing for the laboratory. In addition, the NIFDC has already started the Proficiency Testing for Bioanalysis in September 2017.
Following the passing of the US FDA GLP verification, Medicilon actively implemented the new Chinese GLP requirements. Medicilon is the first batch of the participants and successfully passed NIFDC’s Proficiency Testing for Bioanalysis and was awarded the certificate toady.
Share：
marketing@medicilon.com
ABOUT
